DA Davidson Downgrades OppFi to Neutral, Lowers Price Target to $3
DA Davidson analyst Chris Brendler downgrades OppFi (NYSE:OPFI) from Buy to Neutral and lowers the price target from $6 to $3.
Earnings Scheduled For August 9, 2022
Companies Reporting Before The Bell
• Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.
JMP Securities Maintains Market Outperform on OppFi, Lowers Price Target to $5
JMP Securities analyst David Scharf maintains OppFi (NYSE:OPFI) with a Market Outperform and lowers the price target from $6 to $5.
3 Stocks Under $4 Insiders Are Aggressively Buying
The Nasdaq Composite dropped by over 300 points on Friday despite better-than-expected jobs data for May. Investors, meanwhile, focused on some notable insider trades.
3 Stocks Under $3 Insiders Are Aggressively Buying
US crude oil futures traded higher on Friday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Bring Back the Apes: Three Potential Short Squeezes
April is historically a good month for stocks. This year, not so much--at least the latter part of the month when all mid-month gains were wiped out. May doesn't look much better. Spring, it seems, has not yet sprung in the markets.
OppFi Q1 Adj. EPS $0.01, Sales $100.70M Beat $90.27M Estimate
OppFi (NYSE:OPFI) reported quarterly earnings of $0.01 per share. The company reported quarterly sales of $100.70 million which beat the analyst consensus estimate of $90.27 million by 11.55 percent.
Earnings Scheduled For May 5, 2022
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 784 companies set new 52-week lows.